The injectable drug, at first only used as diabetic issues medication, is the initial drug given that Saxenda (2014) authorized to take care of Continual weight management within the 70% of American Older people who will be obese or overweight. exploration continues to show the performance of semaglutide injections for weight loss. in the end, ph